Owkin, a predictive analytics company that aims to accelerates drug discovery and development, just landed $11 million in Series A funding. The round was led by Otium Venture with participation from Cathay Innovation, Plug and Play, and NJF Capital. This announcement brings the company’s total funding to $13.1 million.
from MobiHealthNews http://ift.tt/2DgXQIJ
January 16, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Digital health deals: HIMSS18 EditionPredictive analytics platform Clew Medical has recently announced its partnership with WakeMed for its clinical trials in the eICU to detect patient deterioration in realtime. Clew uses machine learning algorithms and customi… Read More
Survey: Health app adoption has tripled since 2014New survey data out this week from Accenture shows that healthcare consumers are using more wearables and apps, and are more bullish on virtual care, than ever before. But they also have high expectations for their health tec… Read More
Proteus CMO talks regulation hurdles, future plans for digital pillIt’s still the early days, but the FDA’s approval of Proteus Digital Health and Otsuka Pharmaceuticals’ Abilify MyCite has changed the discussion of digital technology in healthcare. from MobiHealthNews http://ift.tt/2oVJHI2… Read More
NASA's telemedicine docs keep ISS astronauts healthyThere’s no doctor onboard the International Space Station. Because of the costs associated with shipping anything up to space, there’s a carefully chosen selection of medical supplies and devices. For everything else, the six… Read More
Johns Hopkins study: coaching app Sweetch can increase weight loss, activity in prediabetes patientsA recent Johns Hopkins study found that prediabetic patients who used the interactive mobile coaching program Sweetch lost weight and increased physical activity. from MobiHealthNews http://ift.tt/2G9mcSX … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment